Patent · US Active

Crystalline chloro-n-(4-(morpholinomethyl)phenyl)benzamide and crystalline hydrochloride salt

US12116353B1 · kind B1 · utility

0Cited by
2References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 25, 2024
Grant dateOct 15, 2024
Priority date
Expiry dateApr 25, 2044

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07B2200/13
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Crystalline 4-chloro-N-(4-(morpholinomethyl)phenyl)benzamide, crystalline 4-chloro-N-(4-(morpholinomethyl)phenyl)benzamide hydrochloride, methods of preparing the crystalline compounds, pharmaceutical compositions containing the crystalline compounds, and methods of treatment using the crystalline compounds are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.